PRALIDOXIME CHLORIDE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for pralidoxime chloride and what is the scope of freedom to operate?

Pralidoxime chloride is the generic ingredient in three branded drugs marketed by Baxter Hlthcare Corp, Meridian Medcl Techn, and Wyeth Ayerst, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for pralidoxime chloride. One supplier is listed for this compound.

Summary for PRALIDOXIME CHLORIDE

US Patents:	0
Tradenames:	3
Applicants:	3
NDAs:	4
Drug Master File Entries:	5
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	116
Clinical Trials:	1
Patent Applications:	1,312
What excipients (inactive ingredients) are in PRALIDOXIME CHLORIDE?	PRALIDOXIME CHLORIDE excipients list
DailyMed Link:	PRALIDOXIME CHLORIDE at DailyMed

Recent Clinical Trials for PRALIDOXIME CHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Sir Salimullah Medical College Mitford Hospital	Phase 2

See all PRALIDOXIME CHLORIDE clinical trials

Pharmacology for PRALIDOXIME CHLORIDE

Drug Class	Cholinesterase Reactivator
Mechanism of Action	Cholinesterase Reactivators

Anatomical Therapeutic Chemical (ATC) Classes for PRALIDOXIME CHLORIDE

V03AB	Antidotes
V03A	ALL OTHER THERAPEUTIC PRODUCTS
V03	ALL OTHER THERAPEUTIC PRODUCTS
V	Various

US Patents and Regulatory Information for PRALIDOXIME CHLORIDE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Baxter Hlthcare Corp	PROTOPAM CHLORIDE	pralidoxime chloride	INJECTABLE;INJECTION	014134-001	Approved Prior to Jan 1, 1982		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Meridian Medcl Techn	PRALIDOXIME CHLORIDE (AUTOINJECTOR)	pralidoxime chloride	SOLUTION;INTRAMUSCULAR	018986-001	Apr 26, 1983		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Baxter Hlthcare Corp	PRALIDOXIME CHLORIDE	pralidoxime chloride	INJECTABLE;INJECTION	018799-001	Dec 13, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for PRALIDOXIME CHLORIDE

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Baxter Hlthcare Corp	PRALIDOXIME CHLORIDE	pralidoxime chloride	INJECTABLE;INJECTION	018799-001	Dec 13, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.